Revolution Medicines ROE - Return on Equity 2018-2024 | RVMD

Revolution Medicines return on equity for the quarter ending June 30, 2024 was -34.56.

  • Revolution Medicines average return on equity for 2023 was -37.62, a 3.59% decline from 2022.
  • Revolution Medicines average return on equity for 2022 was -39.02, a 51.65% decline from 2021.
  • Revolution Medicines average return on equity for 2021 was -25.73, a 25.07% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Revolution Medicines ROE - Return on Equity 2018-2024 | RVMD

  • Revolution Medicines average return on equity for 2023 was -37.62, a 3.59% decline from 2022.
  • Revolution Medicines average return on equity for 2022 was -39.02, a 51.65% decline from 2021.
  • Revolution Medicines average return on equity for 2021 was -25.73, a 25.07% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.